A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
Abstract Melanoma, being one of the most dangerous forms of skin cancer, is characterized by its aggressive and metastatic nature, with the potential to develop resistance to various treatments. This resistance makes the disease challenging to treat, emphasizing the need for new treatment strategies...
Saved in:
| Main Authors: | Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, Safa Tahmasebi, Sepideh Nasirzadeh Dashtgol, Mahmoud Dehghani-Ghorbi, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03781-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles from adipose-derived stromal/stem cells reprogram dendritic cells to alleviate rat TMJOA by transferring mitochondria
by: Ziyi Mei, et al.
Published: (2025-05-01) -
Strategies for in situ reprogramming of tumor cells into antigen-presenting cells
by: LIN Yongfang, et al.
Published: (2024-11-01) -
Somatic cell reprogramming for Parkinson's disease treatment
by: Xiaozhuo Li, et al.
Published: (2025-03-01) -
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
by: Lucas Schoenfeldt, et al.
Published: (2025-06-01) -
CD91-mediated reprogramming of DCs by immunogenic heat shock proteins requires the kinases AXL and Fgr
by: James Trey F. Harkness, et al.
Published: (2024-12-01)